CannTech PA Issues Recall of Oral Tinctures
MIAMI, April 13, 2026 – CannTech PA, LLC (“CannTech”), a subsidiary of Ayr Wellness, Inc. (“Ayr Wellness”) is initiating a recall of select oral tinctures sold in Pennsylvania, effective [March 24, 2026], in coordination and cooperation with The Pennsylvania Department of Health, Bureau of Medical Marijuana.
The recall is being issued due to a labeling inaccuracy affecting a batch of Revel 1:1 THC:CBD Tincture. The batch of 30 ml bottles is labeled as containing 300 mg total cannabinoids (1:1 THC:CBD) measuring 10 mg per 1ml, while the actual cannabinoid content is 600 mg total cannabinoids (1:1 THC:CBD), which is 20 mg per 1ml. This may lead to incorrect dosing of medication by patients. No other CannTech tinctures or products are subject to this recall.
The specific recalled product information is listed below.
Product Details:
- Product: Revel 1:1 THC:CBD Tincture 300mg (Oral tincture)
- Labeled Strength: 300 mg total cannabinoids, 10mg/ 1ml (1:1 THC:CBD)
- Actual Strength: 600 mg total cannabinoids, 20 mg/ 1ml (1:1 THC:CBD)
- Package Size: 30 ml
- Batch/Lot: PR.250826AI / C2SHREVZEI000016
- Facility: CannTech PA LLC, 545 Keystone Drive, Warrendale, PA 15086
Product Returns:
We recommend that patients discontinue use of this product and return any remaining unused portion to the dispensary where it was purchased. Depending on availability, your dispensary will either issue a replacement tincture of the same brand or provide store credit for future use.
For questions related to the recall, please contact compliance@ayrwellness.com.
About Ayr Wellness Inc.
Ayr Wellness is a vertically integrated U.S. multi-state cannabis operator with over 90 licensed retail locations across Florida, Pennsylvania, New Jersey, Ohio, Nevada, Massachusetts and Virginia. The Company cultivates, manufactures, and retails a broad portfolio of high-quality cannabis products, supporting both medical patients and adult-use consumers. Ayr also offers a growing suite of CPG brands—including Kynd, Haze, and Later Days—designed to meet a wide range of consumer needs across its markets
For more information, please visit www.ayrwellness.com.
Company/Media Contact:
Robert Vanisko
SVP, Public Affairs
T: (786) 885-0397
Email: comms@ayrwellness.com
Released April 13, 2026
